Cardiac risk factors and adverse events among patients receiving first-line CLL treatment in a real-world community practice setting.

被引：0

作者：

Mato, Anthony R.

Tang, Boxiong

Azmi, Soraya

Yang, Keri

Wallis, Nicola

Stern, Jennifer C.

Hedrick, Eric

Huang, Jane

Sharman, Jeff Porter

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[2] BeiGene Ltd, Emeryville, CA USA

[3] BeiGene USA Inc, San Mateo, CA USA

[4] BeiGene Ltd, Cambridge, MA USA

[5] Willamette Valley Canc Inst, Eugene, OR USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期

关键词：

D O I：

10.1200/JCO.2021.39.15_suppl.e24044

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e24044

引用

页数：3

共 50 条

[21] Risk Factors Associated With Major Adverse Cardiovascular Events and Malignancies in Patients With Rheumatoid Arthritis in a Real-World Setting in Japan
Yamaoka, Kunihiro
Sugiyama, Naonobu
Hoshi, Masato
Jo, Joo-Young
Shin, Kichul
Hirano, Toshitaka
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (12)
[22] Understanding real-world treatment patterns of patients with advanced ovarian cancer in the first-line maintenance setting: The FIRST STEP Study
Cooney, Maureen
Kalilani, Linda
Kiss, Zsofia
Golembesky, Amanda
Kobayashi, Monica
Dayma, Megha
Coskuncay, Elif
Schilder, Jeanne
GYNECOLOGIC ONCOLOGY, 2024, 190 : S202 - S203
[23] Adverse events in real-world patients covered by Medicare with metastatic pancreatic ductal adenocarcinoma who received first-line FOLFIRINOX
Dieguez, Gabriela
Tomicki, Samantha
Cockrum, Paul
Hirsch, Jared
Bhatt, Prachi
Kim, George P.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[24] REAL-WORLD TREATMENT PATTERNS AMONG PATIENTS WITH METASTATIC RENAL CELL CARCINOMA RECEIVING FIRST-LINE THERAPY IN THE UNITED STATES VETERAN POPULATION
Bhanegaonkar, A.
Kim, R.
Pandya, S.
Wang, L.
Krulewicz, S.
Pennock, G.
Phatak, H.
VALUE IN HEALTH, 2019, 22 : S116 - S116
[25] Real-world second-line outcomes of NSCLC patients receiving first-line chemotherapy plus immunotherapy
Russano, M.
Cantini, L.
B, A. P.
George, R.
Nunes, P.
Tolba, K.
Dutra, C.
Chico, I.
Cortellini, A.
Pecci, F.
Alessi, J. V.
Ricciuti, B.
Ramkissoon, S.
Aerts, J. G.
Agrawal, S.
Saini, K. S.
ANNALS OF ONCOLOGY, 2024, 35 : S854 - S854
[26] Real-World Treatment Patterns and Healthcare Costs Among Patients with FL with Early Treatment Failure of First-Line Chemoimmunotherapy
Leslie, Lori A.
Emond, Bruno
Lafeuille, Marie-Helene
Vermette-Laforme, Maude
Lefebvre, Patrick
Huang, Qing
AMERICAN HEALTH AND DRUG BENEFITS, 2022, 15 (03): : 75 - 85
[27] The nonadherence and risk factors of eradication failure by sequential therapy as first-line anti-Helicobacter pylori treatment in real-world clinical practice
Lee, Chun-Te
Wu, Chung-Tai
Chang, Wei-Lun
Yang, Er-Hsiang
Hsieh, Ming-Tsung
Chen, Wei-Ying
Sheu, Bor-Shyang
Cheng, Hsiu-Chi
HELICOBACTER, 2024, 29 (01)
[28] First-line systemic real-world treatment of patients with advanced/metastatic NSCLC in the UK
Wang, M.
Dhokia, P.
Menon, S.
Martindale, B.
ANNALS OF ONCOLOGY, 2018, 29 : 22 - 22
[29] Management and Risk Factors for Pleural Effusion in Japanese Patients with Chronic Myeloid Leukemia Treated with First-line Dasatinib in Real-world Clinical Practice
Tsuchiya, Shun
Takaku, Tomoiku
Watanabe, Naoki
Iriyama, Noriyoshi
Kimura, Yuta
Iwanaga, Eisaku
Sugimoto, Kei-ji
Mitsumori, Toru
Ishikawa, Maho
Nakazato, Tomonori
Fujita, Hiroyuki
Sato, Eriko
Hatta, Yoshihiro
Asou, Norio
Kizaki, Masahiro
Tokuhira, Michihide
Ando, Miki
Kawaguchi, Tatsuya
INTERNAL MEDICINE, 2023, 62 (22) : 3299 - 3303
[30] Real-world treatment patterns of adult multiple myeloma patients treated with carfilzomib in the US community oncology setting.
Panjabi, Sumeet
Medhekar, Rohan
Aguilar, Kathleen
Wilson, Thomas
Amirian, E. Susan
Mezzi, Khalid
Rifkin, Robert M.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35

← 1 2 3 4 5 →